ESOPJun 18, 2026, 04:32 PM
Standard BioTools Stockholders Approve 2026 Equity Plan & ESPP Share Increase
AI Summary
Standard BioTools Inc. held its 2026 Annual Meeting of Stockholders, where several key proposals were approved. Stockholders voted to approve the 2026 Equity Incentive Plan and an amendment to the 2017 Employee Stock Purchase Plan, increasing shares reserved for issuance by 1,200,000. Additionally, Class I directors Michael Egholm, Thomas Carey, and Eli Casdin were elected, executive compensation was approved on an advisory basis, and PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for 2026.
Key Highlights
- Stockholders approved the 2026 Equity Incentive Plan by 228,342,854 votes.
- Amendment to 2017 Employee Stock Purchase Plan approved, increasing shares by 1,200,000.
- Michael Egholm, Thomas Carey, and Eli Casdin were elected as Class I directors.
- Advisory vote on executive compensation for 2025 was approved by 209,778,412 votes.
- PricewaterhouseCoopers LLP was ratified as the independent auditor by 330,172,606 votes.
- Approximately 86.04% of total voting power was represented at the Annual Meeting.
Price Impact
More from LAB